Skip to main content
×
Home
    • Aa
    • Aa

Colonization With Methicillin-Resistant Staphylococcus aureus in ICU Patients Morbidity, Mortality, and Glycopeptide Use

  • Maité Garrouste-Orgeas (a1), Jean-Francois Timsit (a1) (a2), Hatem Kallel (a1), Adel Ben Ali (a3), Marie Francoise Dumay (a1), Benedicte Paoli (a1), Benoit Misset (a1) and Jean Carlet (a1)...
Abstract
AbstractObjective:

To determine the impact of methicillin-resis-tant Staphylococcus aureus (MRSA) colonization on the occurrence of S aureus infections (methicillin-resistant and methicillin-suscep-tible), the use of glycopeptides, and outcome among intensive care unit (ICU) patients.

Design:

Prospective observational cohort survey.

Setting:

A medical-surgical ICU with 10 single-bed rooms in a 460-bed, tertiary-care, university-affiliated hospital.

Patients:

A total of 1,044 ICU patients were followed for the detection of MRSA colonization from July 1, 1995, to July, 1 1998.

Methods:

MRSA colonization was detected using nasal samples in all patients plus wound samples in surgical patients within 48 hours of admission or within the first 48 hours of ICU stay and weekly thereafter. MRSA infections were defined using Centers for Disease Control and Prevention standard definitions, except for ventilator-associated pneumonia and catheter-related infections, which were defined by quantitative distal culture samples.

Results:

One thousand forty-four patients (70% medical patients) were included in the analysis. Mean age was 61±18 years; mean Simplified Acute Physiologic Score (SAPS) II was 36.4±20; and median ICU stay was 4 (range, 1-193) days. Two hundred thirty-one patients (22%) died in the ICU. Fifty-four patients (5.1%) were colonized with MRSA on admission, and 52 (4.9%) of 1,044 acquired MRSA colonization in the ICU. Thirty-five patients developed a total of 42 S aureus infections (32 MRSA, 10 methi-cillin-susceptible). After factors associated with the development of an S aureus infection were adjusted for in a multivariate Cox model (SAPS II >36: hazard ratio [HR], 1.64; P=.09; male gender: HR, 2.2; P=.05), MRSA colonization increased the risk of S aureus infection (HR, 3.84; P=.0003). MRSA colonization did not influence ICU mortality (HR, 1.01; P=.94). Glycopeptides were used in 11.4% of the patients (119/1,044) for a median duration of 5 days. For patients with no colonization, MRSA colonization on admission, and ICU-acquired MRSA colonization, respectively, glycopeptide use per 1,000 hospital days was 37.7, 235.2, and 118.3 days. MRSA colonization per se increased by 3.3-fold the use of glycopeptides in MRSA-colonized patients, even when an MRSA infection was not demonstrated, compared to non-colonized patients.

Conclusions:

In our unit, MRSA colonization greatly increased the risk of S aureus infection and of glycopeptide use in colonized and non-colonized patients, without influencing ICU mortality. MRSA colonization influenced glycopeptide use even if an MRSA infection was not demonstrated; thus, an MRSA control program is warranted to decrease vancomycin use and to limit glycopeptide resistance in gram-positive cocci.

Copyright
Corresponding author
Service de Réanimation Polyvalente, Fondation Hopital Saint Joseph, 185 Rue Raymond Losserand, 75014 Paris, France
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

4. TL Smith , ML Pearson , KR Wilcox , PH Cosme Cruz , MV Lancaster , B Robinson-Dunn , et al.Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;340:493501.

6. JL Vincent , DJ Bihari , PM Suter , HA Bruining , J White , MH Nicolas-Chanoin , et al.The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA 1995;274:639644.

7. JR Le Gall , S Lemeshow , F Saulnier . A new Simplified Acute Physiologic Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:29572963.

9. JF Timsit , B Misset , FW Goldstein , J Carlet . Reappraisal of distal diagnostic testings in the diagnosis of nosocomial pneumonia. Chest 1995;108:16321639.

13. AM Stamm , MN Long , B Belcher . Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus. Am J Infect Control 1993;21:7074.

14. E Girou , G Pujade , P Legrand , F Cizeau , C Brun-Buisson . Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1999;27:543550.

19. J Fierobe , D Deere , C Muller , JC Lucet , JP Marmuse , J Mantz , et al.Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization. Clin Infect Dis 1999;29:12311238.

23. WA Knaus , JE Zimmerman , DP Wagner , EA Draper , DE Lawrence . APACHE—Acute Physiologic and Chronic Health Evaluation: a physiologically based classification system. Crit Care Med 1981;9:591597.

24. A Bueno-Cavanillas , M Delgado-Rodriguez , A Lopez-Luque , S Schaffino-Cano , R Galvez-Vargas . Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med 1994;22:5560.

26. SK Fridkin , JR Edwards , SC Pichette , ER Pryor , JE McGowan , FC Tenover , et al.Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis 1999;28:11191125.

27. K Hiramatsu , H Hanaki , T Ino , K Yabuta , T Oguri , FC Tenover . Methicillin-resistant Staphylococcus aureus strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135136.

33. CD Hamilton , R Drew , SW Janning , JK Latour , S Hayward . Excessive use of vancomycin: a successful intervention strategy at an academic medical center. Infect Control Hosp Epidemiol 2000;21:4245.

36. C Chaix , I Durand-Zaleski , C Alberti , C Brun-Buisson . Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:17451751.

37. A Asencio , A Guerrero , C Querada , M Lizan , M Martinez-Ferrer . Colonization and infection with methicillin-resistant Staphylococcus aureus: associated risk factors and eradication. Infect Control Hosp Epidemiol 1996;17:2028.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 2 *
Loading metrics...

Abstract views

Total abstract views: 117 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 26th April 2017. This data will be updated every 24 hours.